{"claimId":"clm_ec_b13-ginkgo-inflammation","version":1,"status":"current","verdict":"Ginkgo for inflammation: Grade B at moderate certainty. Systematic review and meta-analysis of 17 RCTs (1104 participants): Ginkgo biloba leaf extract significantly reduced serum CRP, IL-6, and TNF-alpha versus placebo. Effect on CRP was strongest at higher baseline inflammation (CRP ≥3 mg/L) and lower doses (<500 mg/day). One of the more consistent anti-inflammatory signals in this dataset.","direction":"benefit","magnitude":{"metric":"other","value":null,"unit":"","ci95":null,"humanReadable":"Systematic review and meta-analysis of 17 RCTs (1104 participants): Ginkgo biloba leaf extract significantly reduced serum CRP, IL-6, and TNF-alpha versus placebo. Effect on CRP was strongest at higher baseline inflammation (CRP ≥3 mg/L) and lower doses (<500 mg/day). One of the more consistent anti-inflammatory signals in this dataset.","baselineAbsoluteRisk":null},"certainty":"moderate","clinicalMeaning":"small_but_potentially_useful","applicability":{"appliesTo":["adults, especially with elevated baseline inflammation"],"doesNotApply":["children"],"unknown":["pregnancy"]},"safetyQualifiers":["serious_with_warfarin","moderate_with_ssri"],"evidenceBundleId":"eb_ec_b13-ginkgo-inflammation","citations":[{"pmid":"35781715","design":"peer-reviewed"}],"reviewedBy":{"name":"Substrate editorial","credential":"Independent research collective"},"reviewedAt":"2026-07-16T16:41:04.592Z","dateModified":"2026-07-16T16:41:04.592Z","methodologyVersion":"v1","methodologyDoi":"https://doi.org/10.5281/zenodo.21364236","canonicalUrl":"https://evidencebased.info/interventions/ginkgo/inflammation","attribution":"Substrate (evidencebased.info), claim clm_ec_b13-ginkgo-inflammation v1, reviewed 2026-07-16","license":"CC-BY-4.0 — attribution with link required"}